Health Condition 1: L64- Androgenic alopecia
Conditions
Interventions
Intervention1: Oral minoxidil + platelet rich plasma: 2.5mg once daily oral minoxidil for 3 months and 3 sessions at monthly intervals of prp sesions will be planned.
Control Intervention1: Topical M
Sponsors
Dr Paridhi Vaidh
Eligibility
Inclusion criteria
Inclusion criteria: 1. All consenting male patients aged 18-45 yrs. 2. All new clinically diagnosed cases with androgenetic alopecia of grade: III-VI according to Hamilton and Norwood classification
Exclusion criteria
Exclusion criteria: 1.Patients with a history of Autoimmune disease and Severe systemic illness (such as uncontrolled DM or hypertension, liver or renal diseases, cardiovascular problems) 2.Any patients with known sleeping disorders. 3.Immunocompromised patients. 4.Patient with unrealistic expectations. 5.Alopecia caused by other factors such as telogen effluvium, alopecia areata, or scarring alopecia. 6.Patients who are positive for HIV/ HBsAg /HCV/ VDRL
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oral minoxidil plus platelet rich plasma is considered superior to topical minoxidil plus platelet rich plasma for the treatment in terms of increase in hair density of males with androgenetic alopecia.Timepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Patient Satisfaction score 2.Dermatology life quality indexTimepoint: baseline , 3 months | — |
Countries
India
Contacts
Public ContactDr Chinmoy Raj
KALINGA INSTITUTE OF MEDICAL SCIENCES
Outcome results
None listed